Actively Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
Led by Novartis Pharmaceuticals · Updated on 2026-05-05
500
Participants Needed
16
Research Sites
772 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is multicenter, primary data collection, non-interventional registry study to assess long-term safety, secondary malignancy risk, and effectiveness of tisagenlecleucel in patients with B-cell malignancies in a routine clinical practice setting in Korea.
CONDITIONS
Official Title
Long-term Follow up Local Registry Study of Kymriah in South Korea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who receive tisagenlecleucel infusion in the commercial setting, treated under a managed access program or other pathway, e.g., when product was manufactured for the commercial setting but turned out to be out of specification (OOS).
- Consented to data collection.
You will not qualify if you...
- Patients who are enrolled or will be enrolled in the Novartis long term follow-up protocol CCTL019A2205B.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 16 locations
1
Novartis Investigative Site
Bundang Gu, Gyeonggi-do, South Korea, 13620
Actively Recruiting
2
Novartis Investigative Site
Seongnam-si, Gyeonggi-do, South Korea, 463-712
Actively Recruiting
3
Novartis Investigative Site
Gyeonggi-do, Korea, South Korea, 10408
Actively Recruiting
4
Novartis Investigative Site
Incheon, Korea, South Korea, 405 760
Actively Recruiting
5
Novartis Investigative Site
Seoul, Korea, South Korea, 02841
Actively Recruiting
6
Novartis Investigative Site
Seoul, Korea, South Korea, 08308
Actively Recruiting
7
Novartis Investigative Site
Seoul, Seoul, South Korea, 03080
Actively Recruiting
8
Novartis Investigative Site
Seoul, Seoul, South Korea, 06351
Actively Recruiting
9
Novartis Investigative Site
Seoul, Seoul, South Korea, 150-713
Actively Recruiting
10
Novartis Investigative Site
Busan, South Korea, 49201
Actively Recruiting
11
Novartis Investigative Site
Jeollanam, South Korea, 519763
Actively Recruiting
12
Novartis Investigative Site
Seoul, South Korea, 03722
Actively Recruiting
13
Novartis Investigative Site
Seoul, South Korea, 04401
Actively Recruiting
14
Novartis Investigative Site
Seoul, South Korea, 05505
Actively Recruiting
15
Novartis Investigative Site
Seoul, South Korea, 06591
Actively Recruiting
16
Novartis Investigative Site
Ulsan, South Korea, 44033
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here